BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

OncoBayes’ OB-001 Shows Potential to Overcome ADC Resistance and Boost Brain Penetration of Cancer Drugs

OncoBayes, a privately held clinical-stage pharmaceutical company, announced the successful completion of preclinical work with OB-001, demonstrating the p...

October 08, 2026 | News

Bausch + Lomb Advances Oral Dry AMD Therapy BL1243 Following FDA Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced progress i...

October 08, 2026 | News

QIAGEN Expands AI Push with New Tools for Biological Research and Drug Discovery

New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN D...

October 08, 2026 | News

EpiSign, Geneyx Partner to Integrate Genomic and Epigenomic Analysis for Rare Diseases

Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform EpiS...

October 07, 2026 | News

Genmab’s Rina-S Shows Durable Response in Platinum-Resistant Ovarian Cancer

Treatment with Rina-S® 120 mg/m² every three weeks demonstrated a clinically meaningful objective response rate (ORR) and durable median durat...

October 06, 2026 | News

Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | News

Sartorius and MAbSilico Unite AI and Cell Line Development to Accelerate Biologics Discovery

Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line development The integrate...

October 02, 2026 | News

Vetter Accelerates Injectable Manufacturing Expansion to Meet Rising Global Demand

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-and-finish network to further s...

September 29, 2026 | News

FDA Approves Mirum and Incyte’s Atebrioz for Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz...

September 28, 2026 | News

CooperVision Opens Global Innovation Hub in UK, Unveils Six Contact Lens Advancements

CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced si...

September 25, 2026 | News

Turbine, Daiichi Sankyo Expand Virtual Biology Collaboration to Accelerate ADC Discovery

Turbine, a leading virtual biology company, announced the expansion of its collaboration with Daiichi Sankyo following the successful completio...

September 25, 2026 | News

Bio-Techne Shareholders Approve Acquisition by Merck KGaA

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne ...

September 25, 2026 | News

European Commission Approves First-in-Class Obicetrapib for LDL-C Reduction

- First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions with favorable tolerability...

September 25, 2026 | News

Bio-Techne Opens Düsseldorf Flagship Centre to Accelerate Life Sciences Innovation Across Europe

New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and ...

September 24, 2026 | News

Stay Connected